Answer
Women of childbearing potential must use effective contraception during belimumab (Benlysta) treatment and for at least 4 months after their last treatment.
Sources for this answer
- Benlysta 120 mg and 400 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 35Document updated
Sources checked